Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
CellSolutions
AddedFeb 18, 2024
UpdatedJun 18, 2026
CellSolutions

CellSolutions

Seed

CellSolutions: Quality liquid-based cytology preparation and evaluation system provider.

HQ
Greensboro, NC, US
Founded
2007
Overview
Compare
Fundraising
Employees
Website

Founded with a mission to enhance cytology diagnostics, CellSolutions specializes in providing high-quality liquid-based preparation and evaluation systems for cytology applications. Their comprehensive product line includes tools for sample collection, preservation, slide preparation, and digital evaluation of cytology samples. The company aims to offer flexible and efficient solutions suitable for laboratories of all sizes, ensuring accurate and timely diagnostic results.

Notable for their innovative BestCyte system, an interactive and automated cytology screening platform, CellSolutions has made significant strides in the field of digital cellular imaging. This web-based software enables secure and remote screening and diagnosis, revolutionizing how cytological evaluations are conducted. The company's impact is evident in its ability to streamline laboratory workflows and improve diagnostic accuracy, making it a trusted partner in the medical diagnostics industry.

CellSolutions - Similar Companies

Cell Microsystems logo

Cell Microsystems

Cellia Science logo

Cellia Science

celliasci.com

Celula logo

Celula

Cellens logo

Cellens

cellensinc.com

RareCyte logo

RareCyte

rarecyte.com

Cellara logo

Cellara

Sampling Human logo

Sampling Human

samplinghuman.com

Viatar CTC Solutions logo

Viatar CTC Solutions

CytoMag logo

CytoMag

Techcyte logo

Techcyte

techcyte.com

Histolix logo

Histolix

histolix.com

Cellay logo

Cellay

cellayinc.com

CellMax Life logo

CellMax Life

cellmaxlife.com

Cytocybernetics logo

Cytocybernetics

Celosis logo

Celosis

CellSolutions - Quick Facts

Who are CellSolutions' competitors?

Companies similar to CellSolutions include Cell Microsystems, Cellia Science, Celula and Cellens.

When was CellSolutions founded?

CellSolutions was founded in 2007.

Where is CellSolutions' headquarters located?

CellSolutions' headquarters is located in Greensboro, NC, US.

When was CellSolutions' last funding round?

CellSolutions' most recent funding round was for $900k (USD) in July 2018.

How much has CellSolutions raised to-date?

As of Jul 26, 2018, CellSolutions has raised a total of $900k (USD).

How many employees does CellSolutions have?

CellSolutions has 17 employees as of Feb 5, 2024.

CellSolutions - Classification

Industry
  • Hardware
Ownership
  • Private
Technology
  • Analytics
Geographic Exposure
  • Global
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Cytology Systems
Tags
  • Biotech
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
SIC
  • 5000Wholesale Trade-durable Goods
  • 5040Professional And Commercial Equipment And Supplies
  • 5047Medical, Dental, And Hospital Equipment And Supplies
Show 7 more industry codes
NAICS
  • 330000Manufacturing
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 3900Miscellaneous Manufacturing Industries
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified